Insurance and payers
Digital Health Intelligence & Strategy for Insurers
Identify digital health partnerships that improve member outcomes, risk insight, engagement, and sustainable economics.

Prioritise member, risk, care-management, and operational problems where digital health can create measurable value.
Compare ventures by maturity, evidence, customer traction, engagement model, and insurer relevance.
Track payer activity, emerging categories, partnership models, and differentiated positions across markets.
The decision context
Payer innovation must connect member value with operational and economic outcomes
Insurers can access thousands of solutions across prevention, navigation, chronic care, diagnostics, behavioural health, underwriting, and claims. Category labels alone do not show which ventures can engage members, integrate with existing operations, or sustain an insurer partnership.
Galen Growth helps payer teams prioritise opportunity areas, compare markets and business models, identify credible partners, and test strategic fit using evidence that extends beyond the pitch deck.
What Galen Growth evaluates
From category opportunity to accountable partnership
Each engagement starts with the decision, then brings together the market, company, clinical, partnership, and execution evidence required to answer it.
Payer digital health strategy
Translate member needs, claims priorities, and business objectives into a focused innovation roadmap.
Explore capability →02Healthtech partner scouting
Identify solutions for prevention, underwriting, engagement, navigation, and care-management use cases.
Explore capability →03Partnership due diligence
Test a candidate partner against commercial, clinical, organisational, and market evidence before commitment.
Explore capability →04Competitive intelligence
Benchmark competitor portfolios, investments, partnerships, category coverage, and geographic activity.
Explore capability →05Market prioritisation
Compare digital maturity, category depth, local partners, and adoption conditions across target markets.
Explore capability →06Portfolio evaluation
Review pilots and partnerships for evidence, overlap, strategic contribution, and fitness to scale.
Explore capability →Powered by HealthTech Alpha
Healthtech intelligence for insurers, organised around the use case
HealthTech Alpha makes it possible to compare ventures across partnerships, customers, funding, clinical evidence, market activity, and organisational maturity. We pair those records with payer-specific criteria to expose the difference between category momentum and a credible insurer proposition.
Explore HealthTech Alpha- Insurer partnership benchmarks
- Member and clinical value signals
- Commercial maturity and traction
- Market and category comparisons
Methodology
From strategic question to accountable action
- Define the value case
Set the member, clinical, risk, operational, and economic outcomes the decision must support.
- Map the category
Structure relevant models, ventures, competitors, and partnership activity.
- Evaluate insurer fit
Compare evidence, engagement, integration, economics, maturity, and strategic relevance.
- Prioritise engagement
Recommend categories, markets, partners, diligence questions, and measurable next steps.
Relevant work
How Galen Growth has supported related decisions
Helping an APAC Insurer Prioritise Markets, Categories and Venture Targets
Enabled regional leadership to focus investment, partnership scouting and innovation resources on the most defensible APAC opportunities.
Read case study →Case studySourcing HealthTech Ventures to Power Non-Fluid Underwriting
Enabled the re-insurer to advance partnership evaluation with a qualified, criteria-matched shortlist.
Read case study →Case studyPressure-Testing a Digital Health Partnership Before Commitment
Enabled the investment committee to confirm, or challenge, the preferred partnership on a defensible basis.
Read case study →Case studyMapping Competitor Moves to Set a Differentiated APAC Strategy
Enabled leadership to adopt a defensible follow-or-differentiate stance by market and therapeutic area.
Read case study →Related intelligence
Research for this decision context
Explore Galen Growth analysis and reports built from the same digital health evidence base.
FAQ
Common questions
What is digital health strategy for insurers?
It aligns digital health categories and partnerships with insurer priorities such as prevention, member engagement, underwriting, care management, claims, and sustainable healthcare economics.
How are potential insurance partners evaluated?
We compare strategic relevance, clinical and commercial evidence, member engagement, integration requirements, organisational maturity, and experience with insurer or enterprise customers.
Can Galen Growth benchmark other insurers?
Yes. Competitive intelligence can track insurer partnerships, investments, programmes, markets, and category positions over time.
Who we help
